{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:13:18Z","timestamp":1780978398545,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ebiom.2020.102836","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T10:37:31Z","timestamp":1592649451000},"page":"102836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-909X","authenticated-orcid":false,"given":"Thomas R.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Wurfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ulevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102836_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs and LAMPs in innate immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.ebiom.2020.102836_bib0002","doi-asserted-by":"crossref","unstructured":"Zhou Z., Ren L., Zhang L., et al. Overly exuberant innate immune response to SARS-CoV-2 infection. Cell Host and Microbe 2020 SSRN: https:\/\/ssrn.com\/abstract=3551623.","DOI":"10.2139\/ssrn.3551623"},{"key":"10.1016\/j.ebiom.2020.102836_bib0003","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41564-019-0371-3","article-title":"Dampened NLRP3 inflammasome inflammation in bats and implications for a special viral reservoir host","volume":"4","author":"Ahn","year":"2019","journal-title":"Nature Microbiol"},{"key":"10.1016\/j.ebiom.2020.102836_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molimm.2014.05.008","article-title":"Toll-like receptor co-receptors as master regulators of the immune response","volume":"63","author":"Di Gioia","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ebiom.2020.102836_bib0005","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1073\/pnas.90.7.2744","article-title":"Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide binding protein and soluble CD14","volume":"90","author":"Pugin","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2020.102836_bib0006","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1164\/ajrccm.155.3.9117029","article-title":"Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome","volume":"155","author":"Martin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ebiom.2020.102836_bib0007","doi-asserted-by":"crossref","unstructured":"Messner C.B., Demichev V., Wendisch D., et al. Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics. medRxiv preprint. Cell Systems 2020. https:\/\/doi.org\/10.1016\/j.cels.2020.05.012.","DOI":"10.1016\/j.cels.2020.05.012"},{"key":"10.1016\/j.ebiom.2020.102836_bib0008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/09680519030090061301","article-title":"An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody","volume":"9","author":"Axtelle","year":"2003","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.ebiom.2020.102836_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.imbio.2004.04.002","article-title":"CD14 is required for influenza A virus-induced cytokine and chemokine production","volume":"209","author":"Pauligk","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.ebiom.2020.102836_bib0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.immuni.2017.09.010","article-title":"By capturing inflammatory lipids released from dying cells, the receptor CD14 induces inflammasome-dependent phagocyte hyperactivation","volume":"47","author":"Zanoni","year":"2017","journal-title":"Immunity"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:33Z","timestamp":1762455693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420302115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":10,"alternative-id":["S2352396420302115"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102836","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102836"}}